Cervical Cancer Screening–Health Professional Version (PDQ®)

SECTIONS

Changes to This Summary (03/04/2016)

Description of the Evidence

Updated statistics with estimated new cases and deaths for 2016 (cited American Cancer Society as reference 1). Also added text to state that from 2008 to 2012, incidence rates stabilized in women younger than 50 years and decreased by 3.0% per year among women aged 50 years or older; from 2003 to 2012, the death rate decreased by 0.9% per year.

Added text to state that a population-based cluster-randomized trial in Argentina, comparing screening uptake using self-collection of samples for human papillomavirus (HPV) DNA testing with that of clinic-based sample collection with cytology and HPV triage, found that self-collection was associated with increased screening, which translated into higher detection of cervical intraepithelial neoplasia 2+ and treatment (cited Arrossi et al. as reference 75).

This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Evidence of Harm

Next section >
About This PDQ Summary